Advertisement

Current Psychiatry Reports

, Volume 9, Issue 5, pp 408–414 | Cite as

When ADHD and substance use disorders intersect: Relationship and treatment implications

  • Timothy E. Wilens
  • Steven Fusillo
Article

Abstract

There has been increasing interest in the overlap between attention-deficit/hyperactivity disorder (ADHD) and substance use disorders (SUDs). In this report, we describe the developmental relationship between ADHD and SUDs. ADHD alone and in combination with co-occurring psychopathology is a risk factor for the development of SUDs in adulthood. Conversely, approximately one fifth of adults with SUDs have ADHD. Pharmacotherapeutic treatment of ADHD in children reduces the risk for later cigarette smoking and SUDs in adulthood. In contrast, medication treatment alone of adults with ADHD and current SUD is inadequate for both ADHD and SUD. Stimulant diversion continues to be of concern, particularly in older adolescents and young adults.

Keywords

Cocaine Bupropion Atomoxetine Acad Child Adolesc Psychiatry Lisdexamfetamine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kessler RC, Adler L, Barkley R, et al.: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006, 163:716–723.PubMedCrossRefGoogle Scholar
  2. 2.
    Biederman J, Faraone S, Mick E: Age dependent decline of ADHD symptoms revisited: impact of remission definition and symptom subtype. Am J Psychiatry 2000, 157:816–817.PubMedCrossRefGoogle Scholar
  3. 3.
    Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994, 51:8–19.PubMedGoogle Scholar
  4. 4.
    Wilens T: Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk and treatment issues. Psychiatr Clin North Am 2004, 27:283–301.PubMedCrossRefGoogle Scholar
  5. 5.
    Schubiner H, Tzelepis A, Milberger S, et al.: Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000, 61:244–251.PubMedCrossRefGoogle Scholar
  6. 6.
    Levin FR, Evans S, Kleber HD: Prevalence of adult attention-deficit/hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998, 52:15–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Faraone SV, Biederman J, Spencer TJ, et al.: Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006, 163:1720–1729. Quiz 1859.PubMedCrossRefGoogle Scholar
  8. 8.
    Faraone SV, Wilens TE, Petty C, et al.: Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict 2007, 16(Suppl 1):24–34. Quiz 33–34.PubMedCrossRefGoogle Scholar
  9. 9.
    Milberger S, Biederman J, Faraone S, et al.: ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997, 36:37–44.PubMedCrossRefGoogle Scholar
  10. 10.
    Wilens TE, Biederman J, Mick E, et al.: Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 1997, 185:475–482.PubMedCrossRefGoogle Scholar
  11. 11.
    Pomerleau O, Downey K, Stelson F, Pomerleau C: Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995, 7:373–378.PubMedCrossRefGoogle Scholar
  12. 12.
    Carroll KM, Rounsaville BJ: History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993, 34:75–82.PubMedCrossRefGoogle Scholar
  13. 13.
    Kolpe M, Carlson GA: Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome. Am J Addict 2007, 16:46–48.PubMedCrossRefGoogle Scholar
  14. 14.
    Biederman, J, Wilens TE, Mick E, et al.: Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995, 152:1652–1658.PubMedGoogle Scholar
  15. 15.
    Mannuzza S, Klein RG, Bessler A, et al.: Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993, 50:565–576.PubMedGoogle Scholar
  16. 16.
    Molina B, Pelham W: Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 2003, 112:497–507.PubMedCrossRefGoogle Scholar
  17. 17.
    Wilens T, Kwon A, Tanguay S, et al.: Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 2005, 14:319–328.PubMedCrossRefGoogle Scholar
  18. 18.
    Biederman J, Wilens T, Mick E, et al.: Is ADHD a risk for psychoactive substance use disorder? Findings from a four year follow-up study. J Am Acad Child Adolesc Psychiatry 1997, 36:21–29.PubMedGoogle Scholar
  19. 19.
    Katusic SK, Barbaresi WJ, Colligan RC, et al.: Substance abuse among ADHD cases: a population-based birth cohort study. Paper presented at the Pediatric Academic Society. Seattle, WA; May 3–6, 2003.Google Scholar
  20. 20.
    Biederman J, Monuteaux M, Mick E, et al.: Is cigarette smoking a gateway drug to subsequent alcohol and illicit drug use disorders? A controlled study of youths with and without ADHD. Biol Psychiatry 2006, 59:258–264.PubMedCrossRefGoogle Scholar
  21. 21.
    Wilens T, Biederman J, Mick E: Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 1998, 7:156–163.PubMedCrossRefGoogle Scholar
  22. 22.
    Wilens TE, Faraone SV, Biederman J, Gunawardene S: Does stimulant therapy of ADHD beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179–185.PubMedCrossRefGoogle Scholar
  23. 23.
    Monuteaux MC, Spencer TJ, Faraone SV, et al.: A randomized clinical trial of bupropion for the prevention of smoking in youth with attention-deficit hyperactivity disorder. J Clin Psychiatry 2007, In press.Google Scholar
  24. 24.
    Brook J, Cohen P, Brook D: Longitudinal study of cooccurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry 1998, 37:322–330.PubMedGoogle Scholar
  25. 25.
    Kellam SG, Ensminger ME, Simon MB: Mental health in first grade and teenage drug, alcohol, and cigarette use. Drug Alcohol Depend 1980, 5:273–304.PubMedCrossRefGoogle Scholar
  26. 26.
    Stanger C, Higgins S, Bickel W, et al.: Behavioral and emotional problems among children of cocaine-and opiate-dependent parents. J Am Acad Child Adolesc Psychiatry 1999, 38:421–428.PubMedCrossRefGoogle Scholar
  27. 27.
    Earls F, Reich W, Jung KG, Cloninger CR: Psychopathology in children of alcoholic and antisocial parents. Alcohol Clin Exp Res 1988, 12:481–487.PubMedCrossRefGoogle Scholar
  28. 28.
    Wilens T, Hahesy A, Biederman J, et al.: Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study. Am J Addict 2005, 14:179–187.PubMedCrossRefGoogle Scholar
  29. 29.
    Biederman J, Faraone SV, Monuteaux MC, Feighner JA: Patterns of alcohol and drug use in adolescents can be predicted by parental substance use disorders. Pediatrics 2000, 106:792–797.PubMedCrossRefGoogle Scholar
  30. 30.
    Khantzian EJ: The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997, 4:231–244.PubMedGoogle Scholar
  31. 31.
    Mannuzza S, Gittelman-Klein R, Konig PH, Giampino TL: Hyperactive boys almost grown up: IV. Criminality and its relationship to psychiatric status. Arch Gen Psychiatry 1989, 46:1073–1079.PubMedGoogle Scholar
  32. 32.
    Wilens TE, Adamson J, Sgambati S, et al.: Do individuals with ADHD self medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict 2007, 16(Suppl 1):14–21. Quiz 22–23.PubMedCrossRefGoogle Scholar
  33. 33.
    Levin ED, McClernon FJ, Rezvani AH: Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 2006, 184:523–539.CrossRefGoogle Scholar
  34. 34.
    Upadhyaya HP, Rose K, Wang W, et al.: Attention deficit hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol 2005, 15:799–809.PubMedCrossRefGoogle Scholar
  35. 35.
    Adler L, Cohen J: Diagnosis and evaluation of adults with ADHD. Psychiatr Clin North Am 2004, 27:187–201.PubMedCrossRefGoogle Scholar
  36. 36.
    Riggs PD: Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 1998, 37:331–332.PubMedCrossRefGoogle Scholar
  37. 37.
    McDermott SP, Wilens TE: Cognitive therapy for adults with ADHD. In Subtypes of Attention Deficit Disorders in Children, Adolescents, and Adults. Edited by Brown T. Washington, DC: American Psychiatric Press; 2000:569–606.Google Scholar
  38. 38.
    Safren SA, Otto M, Sprich S, et al.: Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005, 43:831–842.PubMedCrossRefGoogle Scholar
  39. 39.
    Schubiner H, Saules KK, Arfken CL, et al.: Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002, 10:286–294.PubMedCrossRefGoogle Scholar
  40. 40.
    Riggs PD, Hall SK, Mikulich-Gilbertson SK, et al.: A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 2004, 43:420–429.PubMedCrossRefGoogle Scholar
  41. 41.
    Levin FR, Evans SM, Brooks DJ, et al.: Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 2006, 81:137–148.PubMedCrossRefGoogle Scholar
  42. 42.
    Levin FR, Evans SM, Brooks DJ, Garawi F: Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 2007, 87:20–29.PubMedCrossRefGoogle Scholar
  43. 43.
    Heil SH, Holmes HW, Bickel WK, et al.: Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 2002, 67:149–156.PubMedCrossRefGoogle Scholar
  44. 44.
    Brady KT, Wilens TE, Adler LA, et al.: Atomoxetine treatment of adults with ADHD and comorbid alcohol abuse disorder. Paper presented at the 45th Annual Meeting of the American College of Neuropsychopharmacology. Hollywood, FL; December 3–7, 2006.Google Scholar
  45. 45.
    Wilens TE, Biederman J, Spencer TJ: Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry 1997, 36:45–48.PubMedGoogle Scholar
  46. 46.
    Grabowski J, Roache JD, Schmitz JM, et al.: Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 1997, 17:485–488.PubMedCrossRefGoogle Scholar
  47. 47.
    Volkow ND, Ding Y, Fowler JS, et al.: Is methylphenidate like cocaine? Studies on the pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995, 52:456–463.PubMedGoogle Scholar
  48. 48.
    Spencer T, Biederman J, Ciccone P, et al.: A PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short and long-acting orally administered formulations of methylphenidate in adults. Am J Psychiatry 2006, 163:387–395.PubMedCrossRefGoogle Scholar
  49. 49.
    McCabe SE, Knight JR, Teter CJ, Wechsler H: Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005, 99:96–106.CrossRefGoogle Scholar
  50. 50.
    Poulin C: Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CM AJ 2001, 165:1039–1044.Google Scholar
  51. 51.
    Teter CJ, McCabe SE, LaGrange K, et al.: Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006, 26:1501–1510.PubMedCrossRefGoogle Scholar
  52. 52.
    Kroutil LA, Van Brunt DL, Herman-Stahl MA, et al.: Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 2006, 84:135–143.PubMedCrossRefGoogle Scholar
  53. 53.
    Wilens T, Gignac M, Swezey A, et al.: Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry 2006, 45:408–414.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2007

Authors and Affiliations

  1. 1.Pediatric Psychopharmacology UnitMassachusetts General HospitalBostonUSA

Personalised recommendations